Psychemedics Debt to Equity Ratio 2010-2024 | PMD
Current and historical debt to equity ratio values for Psychemedics (PMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Psychemedics debt/equity for the three months ending September 30, 2024 was 0.01.
Psychemedics Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-09-30 |
$0.00B |
$0.01B |
0.81 |
2024-06-30 |
$0.00B |
$0.01B |
0.76 |
2024-03-31 |
$0.01B |
$0.01B |
0.78 |
2023-12-31 |
$0.01B |
$0.01B |
0.85 |
2023-09-30 |
$0.01B |
$0.01B |
0.90 |
2023-06-30 |
$0.01B |
$0.01B |
0.80 |
2023-03-31 |
$0.01B |
$0.01B |
0.76 |
2022-12-31 |
$0.01B |
$0.01B |
0.74 |
2022-09-30 |
$0.01B |
$0.01B |
0.75 |
2022-06-30 |
$0.01B |
$0.01B |
0.71 |
2022-03-31 |
$0.01B |
$0.01B |
0.68 |
2021-12-31 |
$0.01B |
$0.01B |
0.76 |
2021-09-30 |
$0.01B |
$0.01B |
0.69 |
2021-06-30 |
$0.01B |
$0.01B |
0.88 |
2021-03-31 |
$0.01B |
$0.01B |
0.90 |
2020-12-31 |
$0.01B |
$0.01B |
0.92 |
2020-09-30 |
$0.01B |
$0.01B |
0.85 |
2020-06-30 |
$0.01B |
$0.01B |
0.85 |
2020-03-31 |
$0.01B |
$0.02B |
0.60 |
2019-12-31 |
$0.01B |
$0.02B |
0.64 |
2019-09-30 |
$0.01B |
$0.02B |
0.49 |
2019-06-30 |
$0.01B |
$0.02B |
0.36 |
2019-03-31 |
$0.01B |
$0.02B |
0.38 |
2018-12-31 |
$0.01B |
$0.02B |
0.33 |
2018-09-30 |
$0.01B |
$0.02B |
0.46 |
2018-06-30 |
$0.01B |
$0.02B |
0.45 |
2018-03-31 |
$0.01B |
$0.02B |
0.45 |
2017-12-31 |
$0.01B |
$0.02B |
0.42 |
2017-09-30 |
$0.01B |
$0.02B |
0.48 |
2017-06-30 |
$0.01B |
$0.02B |
0.44 |
2017-03-31 |
$0.01B |
$0.02B |
0.56 |
2016-12-31 |
$0.01B |
$0.02B |
0.60 |
2016-09-30 |
$0.01B |
$0.01B |
0.87 |
2016-06-30 |
$0.01B |
$0.01B |
0.99 |
2016-03-31 |
$0.01B |
$0.01B |
1.03 |
2015-12-31 |
$0.01B |
$0.01B |
0.89 |
2015-09-30 |
$0.01B |
$0.01B |
0.91 |
2015-06-30 |
$0.01B |
$0.01B |
0.89 |
2015-03-31 |
$0.01B |
$0.01B |
0.84 |
2014-12-31 |
$0.01B |
$0.01B |
0.88 |
2014-09-30 |
$0.01B |
$0.01B |
0.82 |
2014-06-30 |
$0.01B |
$0.01B |
0.80 |
2014-03-31 |
$0.01B |
$0.01B |
0.45 |
2013-12-31 |
$0.00B |
$0.01B |
0.35 |
2013-09-30 |
$0.00B |
$0.01B |
0.25 |
2013-06-30 |
$0.00B |
$0.01B |
0.21 |
2013-03-31 |
$0.00B |
$0.01B |
0.21 |
2012-12-31 |
$0.00B |
$0.01B |
0.26 |
2012-09-30 |
$0.00B |
$0.01B |
0.24 |
2012-06-30 |
$0.00B |
$0.01B |
0.24 |
2012-03-31 |
$0.00B |
$0.01B |
0.16 |
2011-12-31 |
$0.00B |
$0.01B |
0.25 |
2011-09-30 |
$0.00B |
$0.01B |
0.16 |
2011-06-30 |
$0.00B |
$0.01B |
0.18 |
2011-03-31 |
$0.00B |
$0.01B |
0.17 |
2010-12-31 |
$0.00B |
$0.01B |
0.22 |
2010-09-30 |
$0.00B |
$0.01B |
0.16 |
2010-06-30 |
$0.00B |
$0.01B |
0.15 |
2010-03-31 |
$0.00B |
$0.01B |
0.14 |
2009-12-31 |
$0.00B |
$0.01B |
0.14 |
2009-09-30 |
$0.00B |
$0.01B |
0.13 |
2009-06-30 |
$0.00B |
$0.01B |
0.14 |
2009-03-31 |
$0.00B |
$0.01B |
0.14 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.014B |
$0.022B |
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|